Replies to post #40729 on Avid Bioservices Inc (CDMO)

[entdoc]

nuke, I put the chances of PPHM reverse split at somewhat south of 50%. But pessimists are right too, but hopefully also somewhat less than 50%. Who is indifferent or encouraging a reverse split of PPHM stock? Such exist.
What is the threat of revolutionary PPHM concepts to "old" biotech? The threat PPHM poses to the MAB marketplace as resistance to anti-PS on the treatment stage lessens, and financial interests adjust to the reality. Reverse split? Does PPHM technology have bullet-proof patent protection?
If not, what? Primacy. PPHM has technical "know-how," experience...paramount. All other anti-phospholipids intended for human consumption will forever be "generic" compared to PPHM's own FDA approved MAB factory Avid, one that clearly has the "know-how." Avid is invaluable to this corporation, and will continue to grow exponentially whether or not Bavi. If the company is sold at this point we must all assert our considerable interest. A reverse split would be the ultimate shake-out, wouldn't it? What if it were announced along with a headline grabbing partnership? Intersting stuff. Hold on!